Hint mode is switched on Switch off
For swift navigation between sections

Bon Natural Life

PDF download

Choose all Reset all
Download Cancel
Organization name
Bon Natural Life Limited
Country name
China
Country of registration
Cayman Islands
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Bon Natural Life Limited operates as a biotech company. The Company focuses on bio-manufacturing of natural products and health solutions in immunity and digestion, BNL owns innovative talents, proprietary natural essence extraction technology, and integrated supply chain.

Awards

News

09/09/2025 BON Announces $18 Million Cooperation Agreement for Innovative Second-Generation Apple Series Health Products
02/09/2025 BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform
02/07/2025 Bon Announces Breakthrough Order for $16 Million Gut-Health Products
All organization news

Documentation

IFRS/US GAAP reports

2024
III q eng
2023
III q eng
2022
III q eng
2021
III q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • SIC
    2833 MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
  • CIK
    0001816815
Registration is required to get access.